A phase II study of Cis-platinum for recurrent corpus cancer.
D000368:Aged; D002945:Cisplatin / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D014594:Uterine Neoplasms / Q000188:drug therapy*
D002945:Cisplatin